With a global pandemic and a fraught trade war, many are wondering if China’s pharmaceutical monopoly presents a national security threat.
Illustration by Nigel Buchanan
WASHINGTON — The baby had so many pustules ravaging his face he could barely open his right eye, a photograph that left the president, national security adviser and close aides nearly speechless with horror.
A global pandemic had begun in a hospital in Oklahoma City. Doctors soon diagnosed smallpox, a virulent, deadly and disfiguring infection that had disappeared from the planet two decades before. What would the president do?
This was the scenario that a cast of Washington power playe
Exclusive longform investigative journalism, Q&As, news and analysis, and data on Chinese business elites and corporations. We publish China scoops you won't find anywhere else.
A weekly curated reading list on China from Andrew Peaple.
A daily roundup of China finance, business and economics headlines.
We offer discounts for groups, institutions and students. Go to our Subscriptions page for details.
European democracies, threatened by Vladimir Putin’s war on Ukraine and Donald Trump’s designs on Greenland, are embarking on historic changes in their defense posture. But China’s grip on the supply of tungsten, gallium and other vital raw materials threatens their plans.
The former official in both of the president’s terms discusses why Trump has become less hawkish on China, and his sudden departure from the administration last year.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OKPrivacy policy
